Introduction: Who Should Seek Diagnostics

Anyone who has received an artificial joint replacement, such as a hip, knee, or shoulder implant, should be aware of the possibility of infection developing around the device. While this complication affects only a small percentage of patients—roughly 1 to 2 percent of those who undergo joint replacement surgery—it is important to recognize when diagnostic testing becomes necessary.^[1][2]

You should consider seeking diagnostic evaluation if you notice any troubling signs following your surgery. Symptoms that warrant immediate medical attention include increased pain or stiffness in a joint that was previously functioning well, swelling around the surgical site, warmth or redness near the implant, drainage from the wound, fever, chills, night sweats, or unexplained fatigue.^[2][6] Some infections develop within the first few days to three months after surgery, while others can appear years later, making it essential to remain vigilant throughout your life with the implant.^[2][3]

Certain individuals face higher risks and should be especially attentive to potential infection signs. If you have diabetes, are a smoker, are obese, have rheumatoid arthritis, have a weakened immune system, or have had previous joint infections or multiple joint replacements, your chances of developing an infection are greater.^[2][3] Anyone who develops an infection elsewhere in the body—such as a urinary tract infection, dental infection, or skin wound—should also seek medical guidance, as bacteria can travel through the bloodstream to the implant site.^[2]

It is also important to understand that the classical signs of infection—such as high fever, widespread infection markers in blood tests, or signs of sepsis—are often absent in medical device site joint infections.^[1] This means you cannot rely solely on feeling obviously ill. Even subtle changes in how your joint feels or functions deserve professional evaluation. Diagnosing these infections is not straightforward, and there is no single universally accepted test that confirms infection in all cases.^[1] This complexity underscores the importance of consulting with healthcare professionals who specialize in orthopedic infections when symptoms arise.

Diagnostic Methods: Identifying the Infection

Diagnosing a medical device site joint infection involves multiple approaches, as no single test can definitively confirm or rule out infection in every case. Healthcare providers use a combination of clinical examination, laboratory tests, imaging studies, and sometimes tissue samples to build a complete picture of what is happening around the implant.^[3][4]

Clinical Examination and History

The diagnostic process typically begins with a thorough clinical examination. Your doctor will ask about your symptoms, when they started, and whether you have any conditions that might increase infection risk. They will examine the joint for signs of warmth, redness, swelling, or drainage. The presence of a sinus tract—an abnormal channel that drains pus from the joint to the skin surface—is a strong indicator of infection.^[1] Understanding the timing of your symptoms is also crucial, as infections are classified based on when they occur: early (less than three months after surgery), delayed (three to twelve or twenty-four months), or late (more than twelve to twenty-four months after surgery).^[3]

Laboratory Blood Tests

Blood tests play an important role in evaluating possible infection, although they are not always conclusive on their own. Doctors commonly measure markers of inflammation in the blood, such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Elevated levels of these markers suggest inflammation or infection, but they are not specific to joint infections and can be elevated for other reasons.^[3] Some guidelines also include newer blood markers, though their interpretation requires expertise and should be considered alongside other findings.

Joint Aspiration and Fluid Analysis

One of the most valuable diagnostic tools is joint aspiration, also called arthrocentesis. In this procedure, a doctor inserts a needle into the joint space to withdraw fluid for analysis. The fluid is then examined under a microscope and sent to the laboratory for various tests.^[1][3]

Laboratory analysis of the joint fluid includes counting white blood cells, which fight infection. A high white blood cell count, particularly an increased number of a specific type called polymorphonuclear cells, suggests infection. The fluid is also cultured in the laboratory to identify any bacteria or fungi present. Growing a microorganism from joint fluid is considered the strongest evidence of infection.^[1] However, it is important to note that cultures do not always detect bacteria, especially if the infection involves organisms that form protective layers called biofilms on the implant surface, making them difficult to detect.^[1][16]

Imaging Studies

Imaging tests help doctors visualize the joint and surrounding tissues. Standard X-rays are often the first imaging test performed. While X-rays can show loosening of the implant or bone changes, they are not very specific for infection and cannot always distinguish infection from other causes of implant failure.^[4]

More advanced imaging may include ultrasound, computed tomography (CT) scans, or magnetic resonance imaging (MRI). These tests can reveal fluid collections, abscesses, or soft tissue changes around the implant. In some cases, doctors use specialized nuclear medicine scans that involve injecting a small amount of radioactive material to detect areas of infection or inflammation.^[3][4]

Tissue Biopsy and Surgical Sampling

If the diagnosis remains uncertain after non-invasive tests, or if surgery is already planned, tissue samples can be obtained directly from the area around the implant. During a surgical procedure, the surgeon takes multiple tissue samples (usually at least three to five) from different locations around the joint. These samples are sent for microbiological culture to identify any organisms and for histological examination, where a pathologist examines the tissue under a microscope to look for signs of infection.^[3][4]

The advantage of surgical sampling is that it provides direct access to the infected area and allows for more accurate identification of the causative organism. However, it is more invasive and is typically reserved for cases where other diagnostic methods have not provided clear answers or when treatment already requires surgical intervention.

Diagnostic Criteria and Scoring Systems

To standardize the diagnosis of joint infections, several organizations have developed diagnostic criteria. These include guidelines from the Musculoskeletal Infection Society (MSIS), the International Consensus Meeting (ICM), and the European Bone and Joint Infection Society (EBJIS).^[3][4] These criteria combine multiple test results—such as the presence of a sinus tract, elevated inflammatory markers, positive cultures, high white blood cell counts in joint fluid, and characteristic tissue findings—to determine the likelihood of infection.

The use of standardized criteria helps healthcare professionals make more consistent and accurate diagnoses. The 2018 ICM criteria, for example, have demonstrated high sensitivity (ability to correctly identify infected joints) and specificity (ability to correctly identify non-infected joints) when properly applied.^[3]

Diagnostics for Clinical Trial Qualification

When patients with medical device site joint infections are considered for participation in clinical trials, additional diagnostic testing may be required beyond what is typically done in routine clinical care. Clinical trials test new treatments, diagnostic methods, or surgical techniques, and they require precise documentation of the infection to ensure that study results are reliable and that participants meet specific eligibility criteria.

Clinical trial protocols often mandate specific diagnostic tests to confirm infection before a patient can enroll. These requirements may include obtaining positive microbiological cultures from joint fluid or tissue samples, documenting elevated inflammatory markers at defined thresholds, and performing imaging studies to assess the extent of infection and any bone or soft tissue involvement.^[3]

Trials may also require testing to identify the specific type of bacteria or fungus causing the infection and to determine the organism’s sensitivity to various antibiotics. This information, obtained through antimicrobial susceptibility testing, helps guide treatment selection and ensures that the experimental treatment being tested is appropriate for the type of infection present.^[3]

Some clinical trials investigating new diagnostic methods may involve novel testing approaches not yet widely available in standard practice. These could include advanced molecular techniques to detect bacterial genetic material, specialized biomarker measurements, or new imaging technologies. Participation in such trials can provide access to cutting-edge diagnostic tools while contributing to scientific knowledge that may benefit future patients.

It is important to understand that clinical trial participation is voluntary, and the diagnostic procedures required may be more extensive than those needed for routine care. Before enrolling, healthcare teams will explain all required tests, their purpose, any associated risks, and how the information will be used in the study. Patients considering clinical trial participation should feel comfortable asking questions about why specific diagnostic tests are needed and what the results might mean for their treatment options.